Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.60 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14667470 | 1.00 | MAPT (0.60) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL11963959 | 1.00 | MAPT (0.60) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL16690263 | 0.89 | SMN1; SMN2 (0.60) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL92080 | 0.86 | MAPT (0.78) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL1357956 | 0.86 | MAPT (0.78) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL9962632 | 0.84 | HPGD (0.59) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL8768841 | 0.84 | MAPT (0.57) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL12287274 | 0.84 | HPGD (0.50) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL213829 | 0.83 | ALDH1A1 (0.51) | MAPTPKMCDK5CDK5R1MAPK1 | |
| SCHEMBL2045676 | 0.83 | CYP2C19 (0.48) | MAPTPKMCDK5CDK5R1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077941-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2012-03-29 | — | — | US | claimed |
| US-8088868-B2 | oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis | BRIDGESTONE CORPORATION (JP) | 2012-01-03 | — | — | US | claimed |
| US-20080146745-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2008-06-19 | — | — | US | claimed |
| US-20240383885-A1 | Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid Overdose | MAKSCIENTIFIC, LLC | 2024-11-21 | — | — | US | disclosed |
| US-12054480-B2 | Compounds for treating cannabinoid toxicity and acute cannabinoid overdose | MAKSCIENTIFIC, LLC (US) | 2024-08-06 | — | — | US | disclosed |
| US-20220033393-A1 | Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid Overdose | MAKSCIENTIFIC, LLC | 2022-02-03 | — | — | US | disclosed |
| EP-3227018-B1 | CHELATION DIRECTED C-H ACTIVATION REACTIONS CATALYZED BY SOLID-SUPPORTED PALLADIUM(II) CATALYSTS | UNIV VIRGINIA COMMONWEALTH (US) | 2021-06-30 | — | — | EP | disclosed |
| US-10000453-B2 | Chelation directed C—H activation reactions catalyzed by solid-supported palladium(II) catalysts | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2018-06-19 | — | — | US | disclosed |
| US-20170362181-A1 | CHELATION DIRECTED C-H ACTIVATION REACTIONS CATALYZED BY SOLID-SUPPORTED PALLADIUM(II) CATALYSTS | VIRGINIA COMMONWEALTH UNIVERSITY | 2017-12-21 | — | — | US | disclosed |
| US-9624171-B2 | Photoinitiator mixtures | BASF SE (DE) | 2017-04-18 | — | — | US | disclosed |
| US-8541509-B2 | Polymers functionalized with protected oxime compounds | BRIDGESTONE CORPORATION (JP) | 2013-09-24 | — | — | US | disclosed |
| US-20120077941-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
| US-8088868-B2 | oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis | BRIDGESTONE CORPORATION (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20110218266-A1 | PHOTOINITIATOR MIXTURES | BASF SE (DE) | 2011-09-08 | — | — | US | disclosed |
| US-20110170209-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
| US-20110134554-A1 | PHOTOINITIATOR MIXTURES | BASF SE (DE) | 2011-06-09 | — | — | US | disclosed |
| US-20100136467-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2010-06-03 | — | — | US | disclosed |
| EP-1702962-B1 | Ink composition containing a photo-acid and a photo-base generator and processes using them | FUJIFILM CORP (JP) | 2008-12-24 | — | — | EP | disclosed |
| US-20080146745-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2008-06-19 | — | — | US | disclosed |
| US-4590145-A | Photopolymerization initiator comprised of thioxanthones and oxime esters | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1986-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100136467-A1 | OXIME ESTER PHOTOINITIATORS | CHRM4, NR2E3, CYP3A4 | MAPT 3589/4885PKM 2429/4885CDK5 1586/4885 |
| US-20240383885-A1 | Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid Overdose | CNR1, CNR2, OPRM1 | MAPT 809/4885PKM 3225/4885CDK5 424/4885 |
| US-20170362181-A1 | CHELATION DIRECTED C-H ACTIVATION REACTIONS CATALYZED BY SOLID-SUPPORTED PALLADIUM(II) CATALYSTS | WASF2, SCO2, SOD1 | MAPT 2594/4885PKM 3442/4885CDK5 3851/4885 |
| US-20220033393-A1 | Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid Overdose | CNR1, CNR2, OPRM1 | MAPT 809/4885PKM 3225/4885CDK5 424/4885 |
| US-10000453-B2 | Chelation directed C—H activation reactions catalyzed by solid-supported palladium(II) catalysts | WASF2, SOD1, CD274 | MAPT 2583/4885PKM 3446/4885CDK5 3889/4885 |
| US-12054480-B2 | Compounds for treating cannabinoid toxicity and acute cannabinoid overdose | CNR1, CNR2, OPRM1 | MAPT 809/4885PKM 3225/4885CDK5 424/4885 |
| US-20110170209-A1 | OXIME ESTER PHOTOINITIATORS | RAD51, CBR3, CBR1 | MAPT 4380/4885PKM 1605/4885CDK5 3042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.